Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Other Non-Current Liabilities (2016 - 2025)

Ultralife (ULBI) has 15 years of Other Non-Current Liabilities data on record, last reported at $3.2 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 20.86% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, down 20.86%, while the annual FY2024 figure was $4.0 million, 6.53% up from the prior year.
  • Other Non-Current Liabilities reached $3.2 million in Q3 2025 per ULBI's latest filing, down from $3.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.3 million in Q2 2024 and bottomed at $1.1 million in Q3 2021.
  • Average Other Non-Current Liabilities over 4 years is $2.8 million, with a median of $3.3 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 34.15% in 2021, then surged 114.38% in 2024.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $1.1 million in 2021, then surged by 242.79% to $3.8 million in 2023, then rose by 6.53% to $4.0 million in 2024, then fell by 19.59% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $3.2 million in Q3 2025, $3.5 million in Q2 2025, and $3.7 million in Q1 2025.